Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Lou

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
Mbio|December 6, 2018
Potent Cas9 Inhibition in Bacterial and Human Cells by AcrIIC4 and AcrIIC5 Anti-CRISPR ProteinsJooyoung Lee, Aamir Mir, Alireza Edraki, et al.
Translational Animal Science|September 18, 2023
Optimal lameness induction model development using amphotericin B in meat goatsMikaela M Weeder, Michael D Kleinhenz, Emily J Reppert, et al.
Cell Reports|September 21, 2022
Single-cell sequencing reveals activation of core transcription factors in PRC2-deficient malignant peripheral nerve sheath tumorXiyuan Zhang, Hannah E Lou, Vishaka Gopalan, et al.
Genetics and Molecular Research : GMR|September 2, 2014
Distribution of H-FABP and ACSL4 gene polymorphisms and their associations with intramuscular fat content and backfat thickness in different pig populationsJ N Chen, Y Z Jiang, W M Cen, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Exploring the differences in the tumor microenvironment and immuno-oncologic targets in pancreatic ductal adenocarcinomas (PDAC) according to <i>KRAS</i> mutational statusE B Faber, Y Baca, J Xiu, et al.
British Journal of Cancer|October 6, 2012
Bevacizumab continuation beyond initial bevacizumab progression among recurrent glioblastoma patientsD A Reardon, J E Herndon, K B Peters, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 2, 2021
Distinct genomic landscapes of gastroesophageal adenocarcinoma depending on PD-L1 expression identify mutations in RAS-MAPK pathway and TP53 as potential predictors of immunotherapy efficacyJ Y Wang, J Xiu, Y Baca, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
Targeting Neutrophil Extracellular Traps to inhibit Colon Cancer Tumor Necrosis and MetastasisE Gazzara, J M Adrover, A Lui, et al.
Scientific Reports|July 2, 2025
Validation of an AI-enabled exome/transcriptome liquid biopsy platform for early detection, MRD, disease monitoring, and therapy selection for solid tumorsJ Abraham, V Domenyuk, N Perdigones, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Mbio|December 6, 2018
Potent Cas9 Inhibition in Bacterial and Human Cells by AcrIIC4 and AcrIIC5 Anti-CRISPR ProteinsJooyoung Lee, Aamir Mir, Alireza Edraki, et al.
Translational Animal Science|September 18, 2023
Optimal lameness induction model development using amphotericin B in meat goatsMikaela M Weeder, Michael D Kleinhenz, Emily J Reppert, et al.
Cell Reports|September 21, 2022
Single-cell sequencing reveals activation of core transcription factors in PRC2-deficient malignant peripheral nerve sheath tumorXiyuan Zhang, Hannah E Lou, Vishaka Gopalan, et al.
Genetics and Molecular Research : GMR|September 2, 2014
Distribution of H-FABP and ACSL4 gene polymorphisms and their associations with intramuscular fat content and backfat thickness in different pig populationsJ N Chen, Y Z Jiang, W M Cen, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Exploring the differences in the tumor microenvironment and immuno-oncologic targets in pancreatic ductal adenocarcinomas (PDAC) according to <i>KRAS</i> mutational statusE B Faber, Y Baca, J Xiu, et al.
British Journal of Cancer|October 6, 2012
Bevacizumab continuation beyond initial bevacizumab progression among recurrent glioblastoma patientsD A Reardon, J E Herndon, K B Peters, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 2, 2021
Distinct genomic landscapes of gastroesophageal adenocarcinoma depending on PD-L1 expression identify mutations in RAS-MAPK pathway and TP53 as potential predictors of immunotherapy efficacyJ Y Wang, J Xiu, Y Baca, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
Targeting Neutrophil Extracellular Traps to inhibit Colon Cancer Tumor Necrosis and MetastasisE Gazzara, J M Adrover, A Lui, et al.
Scientific Reports|July 2, 2025
Validation of an AI-enabled exome/transcriptome liquid biopsy platform for early detection, MRD, disease monitoring, and therapy selection for solid tumorsJ Abraham, V Domenyuk, N Perdigones, et al.
Pageof 8